PHOTO
AGU – Manama, Kingdom of Bahrain: A scientific study that was recently discussed at the Arabian Gulf University (AGU) showed a connection between the human genetic mutations that cause type two diabetes and the pathogenesis of psoriasis as a complication of diabetes.
This was raised during a remote session held to discuss the study, which was conducted and presented by Kuwaiti researcher Ms. Matira Salim Al Wuhaidah, as part of the requirements to obtain the PhD degree in Molecular Medicine from the College of Medicine and Medical Science (CMMS) in AGU.
On this occasion, CMMS Deputy Dean for Higher Studies and Scientific Research Dr Randah Ribhi Hamadeh, explained that the dissertation is the second to be discussed remotely by the Molecular Medicine Programme.
For his part, the key supervisor of the study Dr Moiz Bakhiet stated that the study successfully identified the genetic mutations that cause psoriasis and the complications of diabetes in the genome control and coding areas. He added that the results indicated that genetic mutations and haplogroup in mitochondria could lead to the pathogenesis of psoriasis as a disease and diabetes as complications.
The study was titled "Haplogroup in Mitochondria Reveals the Genetic Basis of Type Two Diabetes in Psoriasis Patients". In addition to Dr Bakhiet, who is the Chief Executive Director of Al Jawhara bint Ebraheem Centre for Molecular Medicine, Genetics and Inherited Disorders (ACMID), the study was also supervised by Molecular Biology Professor in Kuwait University Dr Suad Al Fadhli, as well as Assistant Professor in the Genetics and Molecular Biology Department in the United Arab Emirates Dr Habiba Al Saffar as an external examiner, and Molecular Medicine and Genetics Specialist and Assistant Professor in CMMS Dr Ghada Al Kafaji as an internal examiner.
-Ends-
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
